top of page
 startengine startengine crowdfunding startengine equity crowdfunding startengine campaign management startengine investment platform startengine reg CF startengine reg A+ startengine startup funding raise capital on startengine startengine investor portal startengine campaign dashboard startengine due diligence tools startengine compliance support startengine marketing toolkit startengine referral program startengine community engagement startengine founder resources startengine fees and pricing startengine success stories startengine campaign analytics Series A & Series B Rounds series A funding series B funding pre-series A round pre-series B round series A valuation series B valuation lead investor series A lead investor series B series A term sheet series B term sheet cap table management equity dilution analysis series A pitch deck series B investor deck growth metrics for series A traction metrics for series B bridge financing follow-on funding round convertible note conversion pro-rata rights    private equity investment private equity firm private equity fundraising leveraged buyout (LBO) management buyout (MBO) growth equity venture capital vs private equity mezzanine debt limited partners (LPs) general partners (GPs) fund of funds secondary market transaction portfolio company management fund governance carried interest hurdle rate  internal rate of return (IRR)  distribution waterfall  dry powder exit strategy

Private Equity Practice 

Agriculture 

HOW WE HELP CLIENTS

HOW WE HELP CLIENTS

From seed capital to Series A/B rounds, startup funding is the lifeline of groundbreaking innovation

Venture capital mega-rounds is the ultimate power move for startups aiming to dominate their industry.

These off-market deals offer sky-high returns, long-term wealth-building potential.

Investor relations (IR) is the hidden engine behind skyrocketing stock prices and billion-dollar funding rounds.

pexels-kindelmedia-8566636.jpg

Capital Catalysts: The Investors Igniting Innovation

Their true value lies not just in capital but in strategic introductions to contract manufacturers, enterprise customers, and follow-on co-investors. Tenstorrent, for example, raised over $230 million across multiple VC rounds led by Eclipse and Fidelity, leveraging that backing to refine its neural-network-optimized chip architecture and to pre-sell capacity to hyperscale data centers.

RELATED ARTICLES

>  TECHNOLOGY

>  LIFE SCIENCES

FEATURED INSIGHTS

pexels-cottonbro-6153743.jpg

Private Companies

Startups like CRISPR Therapeutics and Editas Medicine are using CRISPR-Cas9 to correct genetic mutations, offering potential cures for inherited diseases like sickle cell anemia and rare blindness

pexels-mikhail-nilov-8108651.jpg

Institutional Investors 

CVS Health has strategically leveraged a diverse funding ecosystem to support its expansive healthcare initiatives and acquisitions. 

pexels-walidphotoz-33127679.jpg

Private Companies

Deal Value Rebound: Despite a dip in deal count, U.S. PE deal value surged by 50% compared to H1 2024, driven by larger transactions and strategic exits

Connect With Our Private Equity Practice

bottom of page